




































SARJA - SER. A I  OSA - TOM. 421
















Department of Biochemistry and Food Chemistry 




Professor Reijo Lahti 
Department of Biochemistry and Food Chemistry 





Professor Alexander Baykov 
A.N. Belozersky Institute of Physico-Chemical Biology  




Professor Ari Hinkkanen 
A.I. Virtanen Institute 
Department of Biotechnology and Molecular Medicine 





Professor Simo Laakso 





Professor Markku Kulomaa 
Institute of Medical Technology 





ISBN 978-951-29-4659-4 (PRINT) 
ISBN 978-951-29-4660-0 (PDF) 
ISSN 0082-7002 









CBS domains are ~60 amino acid tandemly repeated regulatory modules forming a 
widely distributed domain superfamily. Found in thousands of proteins from all 
kingdoms of life, CBS domains have adopted a variety of functions during evolution, 
one of which is regulation of enzyme activity through binding of adenylate-containing 
compounds in a hydrophobic cavity. Mutations in human CBS domain-containing 
proteins cause hereditary diseases. 
 
Inorganic pyrophosphatases (PPases) are ubiquitous enzymes, which pull 
pyrophosphate (PPi) producing reactions forward by hydrolyzing PPi into phosphate. 
Of the two nonhomologous soluble PPases, dimeric family II PPases, belonging to the 
DHH family of phosphoesterases, require a transition metal and magnesium for 
maximal activity. A quarter of the almost 500 family II PPases, found in bacteria and 
archaea, contain a 120-250 amino acid N-terminal insertion, comprised of two CBS 
domains separated in sequence by a DRTGG domain. These enzymes are thus named 
CBS-PPases. The function of the DRTGG domain in proteins is unknown. 
 
The aim of this PhD thesis was to elucidate the structural and functional differences of 
CBS-PPases in comparison to family II PPases lacking the regulatory insert. To this 
end, we expressed, purified and characterized the CBS-PPases from Clostridium 
perfringens (cpCBS-PPase) and Moorella thermoacetica (mtCBS-PPase), the latter 
lacking a DRTGG domain. Both enzymes are homodimers in solution and display 
maximal activity against PPi in the presence of Co
2+ and Mg2+. Uniquely, the DRTGG 
domain was found to enable tripolyphosphate hydrolysis at rates similar to that of PPi. 
Additionally, we found that AMP and ADP inhibit, while ATP and AP4A activate CBS-
PPases, thus enabling regulation in response to changes in cellular energy status. 
 
We then observed substrate- and nucleotide-induced conformational transitions in 
mtCBS-PPase and found that the enzyme exists in two differentially active 
conformations, interconverted through substrate binding and resulting in a 2.5-fold 
enzyme activation. AMP binding was shown to produce an alternate conformation, 
which is reached through a different pathway than the substrate-induced conformation. 
We solved the structure of the regulatory insert from cpCBS-PPase in complex with 
AMP and AP4A and proposed that conformational changes in the loops connecting the 
catalytic and regulatory domains enable activity regulation. We examined the effects of 
mutations in the CBS domains of mtCBS-PPase on catalytic activity, as well as, 
nucleotide binding and inhibition. 
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SAM  S-adenosyl methionine 
AMP  Adenosine 5’-monophosphate 
ADP  Adenosine 5’-diphosphate 
ATP  Adenosine 5’-triphosphate 
GMP  Guanosine 5’-monophosphate 
GDP  Guanosine 5’-diphosphate 
GTP  Guanosine 5’-triphosphate 
NAD+ Nicotinamide adenine dinucleotide, reduced 
NADH Nicotinamide adenine dinucleotide 
APnA  Diadenosine polyphosphate (n = chain length) 
AP2A  Diadenosine diphosphate 
AP4A  Diadenosine tetraphosphate 
CBS  Cystathionine-β-synthase 
IMPDH 5’-Inosine monophosphate dehydrogenase 
AMPK 5’-Adenosine monophosphate-activated protein kinase 
CLC  Voltage-gated chloride channel 
Pi  Orthophosphate 
PPi  Inorganic pyrophosphate 
PPase  Inorganic pyrophosphatase 
ecPPase PPase from Escherichia coli (family I PPase) 
scPPase PPase from Saccharomyces cerevisiae (family I PPase) 
bsPPase PPase from Bacillus subtilis (family II PPase) 
sgPPase PPase from Streptoccus gordonii (family II PPase) 
smPPase PPase from Streptoccus mutans (family II PPase) 
CBS-PPase  CBS domain-containing PPase (subfamily of family II PPases) 
mtCBS-PPase  CBS-PPase from Moorella thermoacetica 
cpCBS-PPase  CBS-PPase from Clostrium perfringens 
fnCBS-PPase  CBS-PPase from Fusobacterium nucleatum 
Tris  Tris(hydroxymethyl)aminomethane 
MOPS 3-(N-Morpholino)propanesulfonic acid 
EDTA Ethylenediaminetetraacetic acid 
DTPA Diethylenetriaminepentaacetic acid 
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1.1 Protein domains 
 
Proteins evolve by gene duplication, fusion, genetic recombination and/or 
divergence, which modify the properties of the protein in order to increase the fitness 
of the organism in its environment. Protein domains are evolutionarily conserved, 
independently folding and functioning units of protein and organismal evolution with 
shared structural, sequence and functional properties. Structural domains, usually 50-
200 amino acid residues in length, can be combined in different arrangements with 
each other and with other domains of different functions to create multidomain proteins 
with novel or modified properties. These domain combinations can, in turn, evolve to 
generate other proteins and properties. 
 
Domain families and superfamilies, which have evolved from a common ancestor, 
are usually composed of domains shared by only a few other superfamilies, occurring 
in a defined order in sequence (Apic et al. 2001, Kummerfeld & Teichmann 2009). 
The most widely distributed domain families are usually also the most ancient (Orengo 
& Thornton 2005). Multiple domains adjacent to each other are often the result of 
single duplication events, which are then combined with other domains and evolve as a 
single unit (Gough 2005, Bashton & Chothia 2002). This is due to either selection of 
the functional advantage conferred by the resulting combination of domains or because 
the function is created by the fusion of the domains in question (Orengo & Thornton 
2005). Recently duplicated domains usually occur at the ends of proteins (Weiner & 
Moore 2008) and are commonly involved in protein-protein interactions (Basu et al. 
2008). In general, eukaryotes contain proteins composed of more complex 
combinations of multiple domains than bacteria or archaea (Apic et al. 2001, 
Kummerfeld & Teichmann 2009). Approximately 90% of the domains in eukaryotes 
and 70% in bacteria have undergone a duplication event (Chothia et al. 2003). Some 
families have undergone massive expansion during evolution, whereas others are 
highly conserved, reflecting their conserved function throughout life (Woese 2002). 
Other families have expanded through an increase in organismal complexity, requiring 





structural similarity, whereas domain superfamilies share a defined 3D structure due to 
significant divergence of sequence, especially if the domain has evolved specialized 
functions. Domains found in a wide range of different architectures are able to tolerate 
substitution of residues structurally better than other folds, allowing sequence to 
diverge more readily (Murzin 1998, Shakhnovich et al. 2003). The 3D structures of 
domains have been shown to be more conserved than sequence during evolution 
(Chothia & Lesk 1986), and can be used in the identification of distant relatives 
(Orengo 1999). 
 
1.2 CBS domains 
 
Intramolecular association of two tandem ~60 amino acid CBS repeats (CBS1 and 
CBS2) at the N- or C-termini of mainly metabolic enzymes, transcription factors, 
proteases, and various transporters and channels, forms a so-called CBS pair or 
Bateman domain. The first members of the CBS domain superfamily were first 
identified by Alexander Bateman in the genome of Methanococcus jannaschii and 
were named after human cystathionine-β-synthase (Bateman 1997). CBS domains have 
now been observed in over 15000 proteins (Superfamily Database, Gough et al. 2001). 
CBS domains have a conserved secondary and tertiary structure but a low overall 
sequence identity, may exist as standalone proteins or as parts of larger multidomain 
proteins, and seem to have adopted a range of functions during evolution. 
 
As shown in Table 1, the largest number of CBS domains in a given genome is 
found in green plants, where a single genome contains on average 43 proteins with 
CBS domains. Chordates contain 26 domains and prokaryotes only 9.4 domains. 
Specifically, the human genome contains 70 proteins with CBS domains, while e.g. the 
citrus tree (Citrus sinensis) contains 106 CBS proteins or 136 CBS domains. The CBS 
domain superfamily is functionally widespread, occurring primarily in purine 
metabolism (39%), active transport of solutes (12%), selenoamino acid metabolism 
(6%), and methionine metabolism (6%), with the rest distributed sporadically in 
various functional classes (SMART database, Letunic I et al. 2009). CBS domains are 
found in a number of different architectures. The CBS domain-containing proteins in 
humans include cystathionine-β-synthase (Mudd et al. 1964), 5’-IMP dehydrogenase 





voltage-gated chloride channels and transporters (CLC1-7, -Ka, -Kb) (Jentsch & 
Günther 1997), and the CNNM1-4 metal transporters (Wang et al. 2003a). The number 
of CBS domains in a genome probably reflects their functional specialization during 
evolution, where the more complex the organism, the greater are the demands placed 
for regulation of enzymatic function. 
 
Table 1. Species distribution of CBS domains among different phylae. Generated from data in 
the SUPERFAMILY database (Gough et al. 2001). Values in bold are totals and the names in 










Prokarya 1157 10863 10450 9,4 
   Archaea 86 1418 1089 16,5 
   Eubacteria 1071 9445 9361 8,8 
Eukarya 305 6031 4799 19,8 
Green plants 33 1796 1408 54 
   Arabidopsis thaliana  55 42  
Chordata 51 1339 1133 26,2 
   Homo sapiens  78 70  
Arthropoda 32 357 288 11,2 
   Drosophila melanogaster  47 31  
Nematoda 9 219 179 24 
   Caenorhabditis elegans  32 26  
Fungi 118 1536 1153 13 
   Saccharomyces cerevisae  13 10  
Other metazoa 9 145 126 16 
Other eukaryotes 50 639 512 12,8 
Total 1462 16894 15249 11,6 
 
The phyletic, architectural and functional distribution of CBS domains indicates 
that these domains were present and acquired specialized functions very early in 
evolution. The conservation of secondary and tertiary structure in time, despite 
significant changes in the function of individual proteins, supports evolution from a 
single unit. The identification of the ancient origins of these domains might help in 
understanding the functional, structural, mechanistic and evolutionary features shared 
by CBS domains. The aim of Chapter 1.2 of this thesis is to briefly summarize the 
properties of CBS domain-containing proteins, concentrating primarily on the role of 





1.2.1 Structure and function of CBS domains 
 
The first crystal structure of a CBS domain was solved as part of the structure of the 
5’-IMPDH of the Chinese hamster, Cricetulus griseus (Sintchak et al. 1996). Since 
then, at least 64 crystal structures containing CBS domains have appeared in the PDB 
(PDB IDs 1O50, 1PBJ, 1PVM, 1VR9, 1XKF, 1Y5H, 1YAV, 1ZFJ, 2D4Z, 2EF7, 2J9L, 
2JA3, 2OUX, 2PFI, 2QH1, 2QLV, 2QR1, 2QRC, 2QRD, 2QRE, 2RC3, 2RIF, 2RIH, 
2UV4, 2UV5, 2UV6, 2UV7, 2V8Q, 2V92, 2V9J, 2YVZ, 2YVY, 2YVX, 2ZY9, 3B4R, 
3DDJ, 3FHM, 3FNA, 3FV6, 3FWR, 3FWS, 3GBY, 3GHD, 3HF7, 3JTF, 3K2V, 
3K6E, 3KH5, 3KPB, 3KPC, 3KPD, 3KXR, 3L2B, 3L31, 3LFR, 3LFZ, 3LHH, 3LQN, 
3LV9, 3NQR, 3OCO, 3PC2, 3PC3, 3PC4) and 21 publications describing some of 
these structures in the literature (Gómez García et al. 2011, Gómez-García et al. 2010, 
Koutmos et al. 2010, Lucas et al. 2010, Tuominen et al. 2010, Hattori et al. 2009, King 
et al. 2008, Proudfoot et al. 2008, Ragunathan et al. 2008, Sharpe et al. 2008, Amodeo 
et al. 2007, Day et al. 2007, Feng et al. 2007, Hattori et al. 2009, Jin et al. 2007, 
Markovic et al. 2007, Meyer et al. 2007, Xiao et al. 2007, Meyer & Dutzler 2006, 
Miller et al. 2004, Zhang et al. 1999). 
 
Figure 1. A) Secondary structure of CBS domains (Ignoul & Eggermont 2005). Helices are 
shown as dark grey rectangles and sheets as light grey arrows. B) 3D structure of the 
homodimeric CBS dimers of protein MJ0100 in complex with 5-methylthioadenosine and S-






CBS domains exhibit low overall sequence similarity (15-25% depending on 
alignment) but are characterized by the general topology β1-α1-β2-β3-α2 (figure 1A-
B) (Bateman 1997). The structures solved to date reveal a hydrophobic cleft at the β2-
β3 interface of the CBS1 and CBS2 domains between two three-stranded antiparallel 
β-sheets lined by two α-helices on one side of a disk-like structure, forming the binding 
site for various ligands thus far observed to be bound there (AMP, ADP, ATP, AP4A, 
SAM, MTA, ZMP). Interestingly, recent crystal structures contain either one or two 
ligands per CBS pair, where two symmetric cavities on either side of the central cleft 
have been shown to bind ligands. CBS domains may thus bind either one or two 
ligands per domain pair (Lucas et al. 2010). CBS domain-containing proteins mostly 
have either two or four CBS domains in sequence, which form dimers or tetramers in 
solution, while multimers of up to 16 pairs of domains have been observed (Frank et 
al. 2006). Mostly, the interactions between CBS domains are either head-to-head or 
head-to-tail (Rudolph et al. 2007). Interestingly, crystal structures of the CBS domains 
of voltage-gated chloride channels CLC-0, -5 and –Ka, showed that the monomers 
interact at an angle of 90° in contrast to other CBS domain-containing proteins. (Meyer 
& Dutzler 2006, Markovic & Dutzler 2007, Meyer et al. 2007). Despite the low 
sequence similarity between the two CBS domains of a pair, the 3D structures seem to 
be well conserved. 
 
The functions of CBS domains have been reported for only a few proteins, and the 
true in vivo functions, including their role in the regulation of the functional properties 
of CBS domain-containing proteins in most cases remains to be elucidated (Ignoul & 
Eggermont, 2005). To date, CBS domains have been shown to function in a number of 
processes, probably more than one of these in most cases being biological functions for 
this domain. 
 
1. Mediating regulation in response to environmental changes via binding of 
cytosolic AdoMet, ATP, ADP and/or AMP. Examples include AdoMet binding by 
the CBS domains of cystathionine--synthase, where a mutation (D444N) causing 
homocystinuria increased the Kd for SAM. The isolated CBS domains of IMPDH-II 
were found to bind AMP and ATP in a positively cooperative manner, while the full-
length protein also similarly bound and was regulated by ATP (Scott et al. 2004). The 
γ1-3 subunits of AMPK, both full-length and isolated pairs (CBS1-2 and CBS3-4), 





T400N, H383R and R531G) increased dissociation constants for both nucleotides 
(Hardie and Hawley 2001, Scott et al. 2004). The CBS pair of ClC-2 binds ATP, which 
is again weakened by disease-causing mutations (G715E and G826D) (Scott et al. 
2004). The CBS pair of ClC-5 binds ATP (Meyer et al. 2007). ATP binding to the CBS 
domains of CLC-1 regulates gating (Bennetts et al. 2005, Bennetts et al. 2007). 
2. Oligomerization scaffolds. CBS domain-mediated oligomerization has been 
demonstrated in human cystathionine--synthase (Frank et al. 2006) compared to the 
truncated enzyme (Taoka et al. 2002). In contrast, bacterial CLCs lack CBS domains, 
and are dimers, while mammalian CLCs have CBS domains and are also dimeric, so 
CBS domains may not be required for CLC dimerization (Jentsch 2008). 
3. Facilitators of conformational changes resulting in increased transporter 
activity. The MgtE transporter transports Mg2+ ions across the plasma membrane, by 
“sensing” intracellular [Mg2+]. The CBS domain interface thus opens, causing a 
conformational change in a linker domain, which affects gating of the pore (Hattori et 
al. 2007, 2009). The cytoplasmic regions of CLCs contain a CBS pair and regulate 
gating of these chloride channels. Their long cytoplasmic region is connected to a helix 
R, which forms the channel pore and selectivity filter (Dutzler et al. 2002). 
Conformational changes in the cytoplasmic regions are thought to be transmitted to the 
pore via helix R, where disease mutations in the CBS domains affect channel gating 
through conformational changes (Meyer & Dutzler, 2006). 
4. Sensors of ionic strength. The CBS domains in a bacterial glycine betaine 
transporter OpuA detect changes in intracellular ionic strength and thus control 
transport activity. This occurs through ion binding to the CBS2 domain and its 
subsequent interaction with the plasma membrane (Biemans-Oldehinkel et al. 2006). 
5. Modulators of receptor trafficking. CBS domains regulate trafficking of CLC 
chloride channels. Truncation mutations of the CBS2 domain of CLC5 prevent normal 
endosome trafficking (Carr et al. 2003). Also, di-leucine motifs in CBS2 of CLC2 
target the channel to basolateral instead of apical membranes (Pena-Munzenmayer et 
al. 2005). 
6. Binding to nucleic acid. The IMPDH isoforms from humans, E. coli and 
Trichomonas foetus bind around 100 nucleotides of single stranded nucleic acids in 
vivo and in vitro (Maclean et al. 2004). Retinitis pigmentosa P10-linked mutations 
decreased affinity for nucleic acid in vitro (Mortimer et al. 2008). The CBS domains of 





thymus DNA and E-box sequences characteristically bound by HLH transcription 
factors through conformational changes (Aguado-Llera et al. 2010). 
 
Mutations in the CBS domains of human proteins impair the catalytic activity or 
regulatory function of the CBS domains, sometimes resulting in serious diseases 
(Ignoul & Eggermont, 2005). These mutations include, among others, D444N and 
V456P in cystathionine-β-synthase causing homocystinuria (Kluijtmans et al. 1996, 
Shan and Kruger 1998, Maclean et al. 2002, Urreizti et al. 2003, Oliveira et al. 2003), 
R224P and D226N in IMPDH causing retinitis pigementosa (Kennan et al. 2002, 
Bowne et al. 2002), R302Q and H383R in AMPKγ2 causing Wolf-Parkinson-White 
syndrome (Gollob et al. 2001) and hypertrophic cardiomyopathy (Blair et al. 2001), 
respectively. Mutations L766P and R767Q/W in CLC7 cause osteopetrosis (Cleiren et 
al. 2001). Mutations thus affect oligomerization of cysthathionine-β-synthase (Jhee et 
al. 2000a), affect ligand binding in many proteins (Scott et al. 2004, Jin et al. 2007, 
Day et al. 2007, Meyer et al. 2007, Tanaka et al. 2007), affect energy metabolism 
(Scott et al. 2004), alter ion channel gating (Estevez et al. 2004), cause muscle 
disorders (de Diego et al. 1999), and alter protein trafficking (Pena-Munzenmayer et 
al. 2005). Thus CBS domains have a variety of important functions in humans, but 
detailed knowledge of their structure-function relations are still lacking. 
 
1.2.2 Human CBS domain-containing proteins 
 
As shown in figure 2, CBS domains are found in variety of human proteins, such as 
cystathionine-β-synthase, IMP dehydrogenase, CLC chloride channels, AMP-activated 







Figure 2. Neighbor-joining phylogenetic tree of the CBS domains found in the human genome. 
Sequences were retrieved by blast searches of the NR database at the NCBI 
(www.ncbi.nlm.nih.gov). CBSDP is a CBS domain protein with unknown function composed 
of a CBS domain pair. 
Cystathionine-β-synthase (CBS, EC 4.2.1.22) catalyzes a pyridoxal-phosphate 
(PLP)-dependent β-replacement condensation of homocysteine with serine to form 
cystathionine. In mammals, this reaction is a point of feedback control in the 
transulfration pathway, in which cysteine is synthesized from methionine (Banerjee et 
al. 2005, Miles & Kraus 2004, Banerjee et al. 2003). In eukaryotes, CBS is 
allosterically regulated by S-adenosyl-L-methionine (adoMet or SAM), where adoMet 
is the product of the methionine biosynthetic cycle. AdoMet binds to the regulatory 
CBS domains found at the C-terminus of cystathionine-β-synthase (Scott et al. 2004) 
and donates methyl groups to a variety of acceptors. It is produced by methylation of 
L-homocysteine to methionine (Finkelstein 1984a) and controls its own synthesis. 
Thus low adoMet concentrations result in low CBS activity, directing homocysteine 
into methionine and adoMet synthesis (Finkelstein et al. 1975). In contrast, high 
adoMet concentrations result in high CBS activity, directing homocysteine into 






5’-IMP dehydrogenase (IMP dehydrogenase, IMPDH; E.C. 1.2.1.14) catalyzes the 
rate-limiting step in the de novo biosynthetic pathway of GMP, or more specifically, 
the oxidation of IMP into XMP in a reaction which is NAD+-dependent (Shu & Nair 
2008). IMPDH contains two CBS domains in its C-terminus. Guanine nucleotides are 
critical cellular metabolites, involved in RNA, DNA and protein synthesis, including 
various signaling pathways. IMP is a common precursor for both adenylate and 
guanylate biosynthesis and is a substrate for adenylosuccinate synthetase (Pimkin et al. 
2009). Inhibition of IMPDH results in a reduction in the amount of guanylate 
nucleotide synthesis, which among other things, has an antiproliferative effect in 
mammals (Pankiewicz et al. 2003, Pankiewicz et al. 2004). Human IMPDH activity is 
upregulated during increased cell proliferation (Collart & Huberman 1988, Natsumeda 
et al. 1988). It is thus a target for antiviral, antibacterial, anticancer and 
immunosuppressive therapy (Shu & Nair 2008). 
 
5'-Adenosine monophosphate-activated protein kinase (5'-AMP-activated protein 
kinase, AMPK; E.C. 2.7.11.1) is a heterotrimeric serine/threonine protein kinase, 
which regulates cellular energy homeostasis by attaching a phosphate to downstream 
proteins in the cells of nearly every tissue. It is composed of the α, β, and γ-subunits, of 
which there are several isoforms in humans (Stapleton et al. 1996). The γ-subunit 
contains four CBS domains and binds adenylate nucleotides in a cooperative manner. 
AMPK activation results in stimulation of energy-producing and inhibition of energy-
consuming pathways and processes due to metabolic stress that inhibits ATP synthesis 
or accelerates ATP consumption (Hardie & Hawley 2001). Activation results from an 
increase in the ([ADP]+[AMP])/[ATP]-ratio as commonly occurs when ATP is 
consumed by cellular processes (Hardie 2007). 
 
Voltage-gated chloride channels and Cl-/H+ antiporters, both types being CLCs, are 
poorly understood ion channels with 9 members expressed in humans (CLCN1-7, Ka, 
and Kb) (Zifarelli & Pusch 2007). All members have two CBS domains in their C-
terminal cytoplasmic domain, separated by long loops. CLCs are involved in a number 
of physiologically important functions, such as regulation of pH, volume homeostasis, 
organic solute transport, with effects on cellular migration, proliferation and 
differentiation (Jentsch 2008). Some are plasma membrane Cl- channels, which 
function in transport of Cl- through epithelial membranes (Uchida 2000), while others 





are mainly found in the endosomal-lysosomal system where they transport protons or 
chloride into various membrane-enclosed structures (Hara-Chikuma et al. 2005, 
Jentsch 2008). The CLCs 4, 5 and 6 are vesicular transporters, which carry two 
chloride ions and one proton through a membrane. The other CLCs only transport 





Examples of soluble CBS domain-containing proteins with two CBS domains, 
regulated by binding of small-molecule metabolites, and are well-studied include 
cystathionine-β-synthase and IMPDH. The structure of the truncated (without C-
terminal CBS domains) dimeric form of the 551 amino acid human cystathionine-β-
synthase (hCBS, PDB Id 1M54, Taoka S et al. 2002) revealed the composition of the 
CBS monomer: 11 α-helices, 2 β-sheets of four and six strands, and seven 310 helices. 
The 140 residue C-terminus contains the regulatory CBS domains. Truncated hCBS is 
dimeric, which is much more active than the wild type but is also unresponsive to 
AdoMet (Shan et al. 1998, Kery et al. 1998, Meier et al. 2001, Taoka et al. 2002). 
Full-length hCBS can form complexes ranging from dimer to 16-mer (Frank et al. 
2006) but is a functional homotetramer of ~252 kDa (Skovby et al. 1984). The 70 
amino acid N-terminus coordinates a heme cofactor at the surface of the protein, on 
opposite ends of dimeric CBS and provides redox regulation (Jhee et al. 2000, Meier et 
al. 2001). The PLP is buried in a cleft between the N- and CBS domains bound to a 
conserved loop about 20 Å away from the hemes. It also forms a Schiff base with 
K119 forming an internal aldimine in the free enzyme, which plays a key role in 
catalysis. The active site is accessible to the substrates via a narrow channel (Evande et 
al. 2004, Meier et al. 2010, PDB IDs 1JBQ and 1M54). The recently solved full-length 
structure of Drosophila melanogaster CBS as free and in complex with serine and 
aminoacrylate-bound intermediates sheds further light on catalysis and regulation 
(Koutmos et al. 2010). The structure demonstrated similar conformations of N-terminal 
and PLP binding domains as observed previously for truncated hCBS, while interesting 
observations were made regarding the placement of the CBS domains. The CBS 
domains are connected to the catalytic domain by a flexible linker and were observed 





with the CBS domains from the other subunit and are packed head-to-tail in the crystal 
(Koutmos et al. 2010, PDB IDs 3PC2, 3PC3, and 3PC4). 
 
CBS catalyzes a β-replacement reaction via a ping-pong mechanism, in which the 
thiol nucleophile of L-homocysteine attacks the hydroxyl group of serine. Pre-steady 
and steady st te kinetic methods have been applied to study the reaction mechanism of 
yeast CBS (Mudd et al. 1965, Suda et al. 1973, Aitken et al. 2003a, Aitken & Kirsch 
2005). Thus, serine and homocysteine compete for binding to the free enzyme, where 
binding of homocysteine to the serine-E complex also inhibits it (Jhee et al. 2000). 
hCBS is not inhibited by either substrate (Kabil et al. 1999). The reaction proceeds via 
several PLP-bound intermediates. First, an external aldimine is formed by reaction of 
serine and the internal aldimine of the free enzyme. Serine binding results in large 
conformational changes (Kabil et al. 2001). Proton abstraction at the α-carbon yields 
an aminoacrylate intermediate through ternary complex formation in the presence of 
homocysteine (Borcsok & Abeles 1982). The abstraction step is not rate-limiting (Jhee 
et al. 2001, Woehl et al. 1996). Next, nucleophilic attack on the aminoacrylate and 
reprotonation at the α-carbon generates the external aldimine of cystathionine. 
Cystathionine is released from the enzyme after a final transaldimination reaction. The 
release of cystathione from the full-length enzyme is the rate-limiting step of the 
reaction and defines kcat (Taoka et al. 2002), thought to be caused by slow 
conformational changes mediated by the C-terminal CBS domains in the product 
complex (Aitken & Kirsch 2005). In the truncated enzyme from yeast lacking the CBS 
domains, the rate-limiting step is the reaction of homocysteine with the aminoacrylate 
intermediate (Jhee et al. 2001), where slow conformational changes are thought to be 
the cause of the slowed reaction rate (Aitken & Kirsch 2003b). 
 
The C-terminal part of cystathionine β-synthase containing the CBS domains thus 
regulates its activity through steric and allosteric mechanisms. The autoinhibition is 
alleviated by binding of adoMet or by deletion of the regulatory domain, where kcat is 
2.8 s-1 for the wild type, 5.2 s-1 for the adoMet activated enzyme (activated state), and 
10 s-1 for the truncated enzyme (superactivated state, Evande et al. 2002). hCBS is 
activated 2.5-5-fold by adoMet with a dissociation constant of 15 µM (Janosik et al. 
2001). AdoMet, with positively cooperative binding and a Kd of 7.4 µM, activates 






(Taoka et al. 1999). The isolated CBS dimer can bind adoMet with a Kd of 34 µM 




IMPDH is a homotetramer composed of a 400 residue 8-stranded α/β-barrel core 
and a CBS pair at the C-terminus (Zhang et al. 1999, Colby et al. 1999). The core 
domains of the four subunits associate to form a central catalytic site, where the loops 
connecting the secondary structural elements, especially the catalytic cysteine (α6-β6) 
and a “flap” region (α8-β8), contain the catalytically important residues. The four CBS 
pairs are located at the outside of the core complex. 
 
Mechanistic studies of IMPDH proteins have been ongoing for a long time (Brox & 
Hampton 1968, Heyde et al. 1976, Verham et al. 1987, Carr et al. 1993, Xiang et al. 
1996, Wang & Hedstrom 1997, Xiang & Markham 1997, Digits & Hedstrom 1999). 
IMPDH catalyzes the conversion of IMP into XMP with the reduction of NAD+ 
(Pimkin & Markham 2009). IMP binds first to the enzyme and then NAD+ in a random 
addition mechanism (Heyde et al. 1976, Wang & Hedstrom, 1997). A bi-bi mechanism 
has also been suggested (Holmes et al. 1974, Carr et al. 1993, Verham et al. 1987, 
Anderson & Sartorelli 1968, Xiang et al. 1996, Nimmesgern et al. 1996). A 
conformational change occurs and Cys331 (IMPDH-II numbering) attacks position 2 
of IMP. Transfer of the hydride to NAD+ then yields a thioimidate (E-XMP*), which is 
hydrolyzed and a “flap” moves into the NADH site after its release to activate E-XMP* 
hydrolysis via a bound water molecule (Link & Straub 1996, Huete-Perez et al. 1995, 
Sintchak et al. 1996, Pimkin & Markham 2009). XMP release is the rate-limiting step. 
NAD+ binding is uncompetitive with respect to E-XMP and E-XMP* (Hedstrom & 
Wang 1990). 
 
Point mutations in the CBS domain of human IMPDH-I results in the autosomal 
dominant retinitis pigmentosa type 10 (RP10) and Leber Congenital Amaurosis (LCA), 
but have no effect on in vitro activity (Bowne et al. 2002, Kennan et al. 2002, Aherne 
et al. 2004, McLean et al. 2004, Mortimer et al. 2005, Xu et al. 2008, Mortimer et al. 
2008, Gunter et al. 2008, Hedstrom et al. 2008). Scott et al. (2004) showed that the 





cooperative manner, while the effect of ATP was abolished by an RP10-causing 
substitution of human IMPDH-I (R224P) in the second CBS domain of IMPDH-II. 
This observation was not reproduced in later studies (Mortimer & Hedström 2005, 
Pimkin & Markham 2008). In the case of human IMPDH-II, CBS domain truncation 
results in fully active tetrameric enzyme, suggesting that the CBS domains are not 
involved in oligomerization (Nimmesgern et al. 1996). 
 
Human IMPDH-I and -II are significantly different from bacterial and parasitic 
proteins (Franklin & Cook 1969, Hupe et al. 1986, Verham et al. 1987). Evidence for 
independent negative regulation of AMP synthesis by the CBS domains exists. 
Truncation mutants of E. coli IMPDH lacking CBS domains experience large increases 
in adenylate nucleotide concentrations and depletion of cellular PRPP, which leads to 
growth arrest (Pimkin et al. 2009). IMPDH may bind single-stranded nucleic acids, 
demonstrated in vitro and in vivo (McLean et al. 2004, Mortimer & Hedström 2005), 
or may bind DNA and be associate with proteins that are involved in RNA processing 
and splicing regulation in yeast (Matsuno et al. 1995, Cornuel et al. 2002). In fact, 
IMPDH associates with p lyribosomes in tissue culture cells through the CBS domains 
(McLean et al. 2004, Mortimer & Hedström 2005, Mortimer et al. 2008). IMPDH thus 
may have a role in RNA metabolism and transcription regulation, mediated by the CBS 
domains. RP10-linked mutations (Mortimer et al. 2008) and the presence of an extra 
C-terminal domain (Xu et al. 2008) were shown to decrease nucleic acid binding in 
vitro. Therefore RP10-linked mutations may impair the RNA-related function of 


















CBS domains thus form a very large and widely distributed domain superfamily, 
which has been incorporated into a wide array of different architectures and has 
adapted to diverse functions. One of those functions is to serve as allosteric “internal 
inhibitors” of the functional domains of a protein. The fact that this inhibition can be 
relieved (in some cases) by the allosteric binding of adenosine nucleotides or 
derivatives and subsequent conformational changes makes it a very useful sensory 
module for cellular energy status. Slow conformational changes might be an important 
additional level of regulation afforded by CBS domains and are observed for some 
soluble CBS proteins, e.g. cystathionine-β-synthase (Aitken & Kirsch 2005). 
Regulatory enzymes commonly isomerize rapidly, where a factor which slows down a 
structural isomerization could enable more robust enzyme-ligand or –substrate 
interactions. A succession of slow isomerizations could create a timing mechanism 
allowing gradual changes in activity and may provide a broader spectrum of possible 
cellular responses (Purich 2010). Additionally, CBS domains seem to mediate 
oligomerization in some soluble enzymes, which affords an increase in catalytic 
efficiency and in turn allows an additional level of control. 
 
Several unanswered questions remain: 1. What are the molecular mechanisms and 
structural determinants responsible for regulation and communication between the 
CBS domains and the functional core of the protein? 2. Can molecules be developed to 
target CBS domains to either upregulate or downregulate the function of the protein in 
which they reside, e.g. antidiabetic, anticancer, anti-obesity drugs, immunosuppresive 
therapy (Ignoul & Eggermont 2005). 
 
1.3 Family II inorganic pyrophosphatase 
 
1.3.1 Inorganic polyphosphates 
 
Inorganic polyphosphates (PolyP) are composed of a succession of Pi units linked 
by a P-O bond. The functions of polyP, which has been found in all organisms so far 
tested (Brown & Kornberg 2004, Brown & Kornberg 2008, Docampo et al. 2005, 





include: substitute for ATP, metal chelation, phosphate reservoir, buffer, stress 
response (Kornberg 1995, Kulaev et al. 2004). PolyP also seems to be essential for the 
physiological adjustment of microbial growth to environmental conditions, and the 
virulence of some pathogens (Rao et al. 2009), while also stimulating mTOR, a protein 
kinase involved in mammalian cell proliferation (Wang et al. 2003b). 
 
PolyP is mainly broken down by exo- (PPX) and endopolyphosphatases. 
Exopolyphosphatases degrade long polyphosphate chains processively from either 
terminus. There are two nonhomologous families of PPXs, the prototypes of each 
being the Escherichia coli type (ecPPX) (Akiyama et al. 1993) and the yeast type 
(scPPX) (Wurst & Kornberg 1994). Yeast-type PPX is only found in eukaryotes, while 
E. coli-type PPX is found in bacteria and archaea. Yeast-type, or eukaryotic PPX, 
belongs to the DHH family of phosphoesterases, which includes family II PPases and 
RecJ exonucleases, among others (Aravind & Koonin,1998). scPPX and human PPX 
(hPPX), also called hprune (Prunes are PPXs of multicellular animals; Tammenkoski et 
al. 2008), preferentially utilize tripolyphosphate (P3) as substrate, but scPPX is able to 
processively hydrolyze longer chain polyP. Both scPPX and hprune display negligible 
activity against pyrophosphate, which actually inhibits PPX activity (Tammenkoski et 
al. 2007, 2008). Family II PPase, on the other hand, has negligible activity against 
tripolyphosphate and longer-chain polyP but displays maximal activity against 
pyrophosphate (Parfenyev et al. 2001). Both scPPX and family II PPase are very 
similar in structure, composed of two domains linked together by a flexible loop region 
with the active site in the domain interface interface (Tammenkoski et al. 2007, 
Ugochukwu et al. 2007). So far, no enzyme has been shown to hydrolyze both 
pyrophosphate and tripolyphosphate (or longer phosphate chains) directly into 
phosphate at similar rates, although a low PPase activity has been found in a PPX from 
Corynebacterium glutamicum (Lindner et al. 2009). 
 
1.3.2 Family II pyrophosphatase 
 
Inorganic pyrophosphatase (EC 3.6.1.1; subsequently referred to as PPase) 
catalyzes the synthesis and hydrolysis of pyrophosphate (PPi), producing phosphate 
(Pi) and energy in the process. PPi is the shortest linear inorganic polyP produced by 





synthesis, lipid metabolism, polysaccharide and nucleotide synthesis (Klemme 1976), 
in addition to basic metabolic reactions, like photophosphorylation (Baltscheffsky et al. 
1966), oxidative phosphorylation (Baltrop et al. 1963) and glycolysis (Mansurova et al. 
1976). The hydrolysis of PPi pulls the equilibrium of these reactions forward (ΔG
0 = -
17 kcal/mol in vivo; Cooperman 1982, Kornberg 1962, Peller 1976, Nelson et al. 2000, 
Heinonen 2001). Even so, the concentration of PPi in e.g. rat blood and liver cells 
remains above the equilibrium value (Veech et al. 1980). PPi has been shown to 
regulate calcification, cell proliferation and iron transport, thus also being linked to 
certain diseases (Heinonen 2001). Under specific conditions, ATP-dependent 
metabolic reactions may switch to use PPi as an energy source (Huang et al. 2008), and 
further, certain classes of prokaryotes utilize PPi instead of ATP as a central energy 
source in metabolism (e.g. Bielen et al. 2010). PPi thus affects the fidelity and 
efficiency of RNA-, DNA-, and protein synthesis (Lahti 1983). PPases have been 
shown to be essential for the growth of a number of bacteria (Chen et al. 1990, Abu 
Kwaik 1998, Ogasawara 2000). 
 
Three families of non-homologous PPases have been identified so far. The soluble 
family I enzymes, discovered in 1928 by Kay et al., are the most well studied and are 
found in all kingdoms of life (Baykov et al. 1999). The enzymes from E. coli (ecPPase) 
and Saccharomyces cerevisae (scPPase) are the most well-known members of this 
family. The soluble family II enzymes are restricted to some prokaryotic species, 
mostly found in the phylums firmicutes and proteobacteria. Variously called the Bs-
family (Shintani et al. 1998) or the C Class (Young et al. 1998) of soluble PPases, 
family II PPase was initially characterized in Bacillus subtilis by Tono and Kornberg in 
1967, who did not recognize that it belongs to an evolutionarily unrelated family. 
Soluble family I and II PPases have different primary and tertiary structures, catalytic 
efficiencies and cofactor selectivities (Shintani et al. 1998, Young et al. 1998, Merckel 
et al. 2001, Ahn et al. 2001, Parfenyev et al. 2001, Halonen et al. 2005). Although 
different in overall structure, the active site residues essential for catalysis are 
conserved between families (Ahn et al. 2001, Merckel et al. 2001). The third type of 
PPi hydrolyzing enzyme is the membrane-bound PPase, found in plants and some 
bacteria, which uses the energy released upon pyrophosphate hydrolysis to drive proton 






Soluble PPases are additionally regulated by transcriptional and post-translational 
mechanisms. Family I PPases are overexpressed in human cancer tissues (Chen et al. 
2002, Lexander et al. 2005), upon decrease in phosphate concentration in certain 
bacteria (Gomez-Garcia et al. 2003), in the cold in wheat (Gulick et al. 2005), at 
increased salinity in barley (Ueda et al. 2006), and upon calorie restriction in cows 
(Kuhla et al. 2007). Phosphorylation has been shown to prevent self-fertilization in the 
field poppy flower (de Graaf et al. 2006). Family II PPases are also phosphorylated in 
Streptococcus agalactiae (Rajagopal et al. 2003). Interestingly, about a quarter of 
family II PPases contain a regulatory insert in the N-terminal DHH domain (Paper I). 
The insert is composed of two CBS domains and a DRTGG domain, and thus these 
enzymes are called CBS-PPases. CBS-PPases are inhibited by AMP and ADP, while 
ATP and APnA (n = the number of phosphate residues) activate several-fold (Papers I, 
V). 
 
The following is intended to provide the reader an overview of the mechanism of 
family II pyrophosphatases, which will allow a better understanding of the properties 





1.3.3 Structure and mechanism 
 
Several structures of family II PPases have been solved (table 2). As shown in 
figure 3, family II PPases are composed of two domains, termed the DHH and DHHA2 
domains. The active site is located in the interface of these domains. The N-terminal 
DHH domain binds two metal ions, that are crucial for catalysis. The C-terminal 
DHHA2 domain binds substrate. Movement of the C-terminal domain over the N-
terminal domain creates a catalytically competent structure (Ahn et al. 2001, Merkel et 




Figure 3. Cartoon representation of the structure of the family II PPase of Streptococcus 
gordonii (sgPPase) determined at 1.75 Å resolution with imidodiphosphate (PNP), F- and Mg2+ 
bound to the active site located between the DHH and DHHA2 domains (PDB ID 2HAW, 




















1K20 1.50 Ahn et al. 2001 




Fabrichniy et al. 
2004 
Bacillus subtilis N-term/Mn2+, SO4
2- 
1WPN 1.30 


















Rantanen et al. 
2007 




Fabrichniy et al. 
2007 















3L31 2.27 Paper III 
 
The catalytic mechanism of family II enzymes (Parfenyev et al. 2001, Konopka et 
al. 2002, Zyryanov et al. 2002, Zyryanov et al. 2004a, 2004b, Fabrichniy et al. 2004, 
Halonen et al. 2005, Fabrichniy et al. 2007) are not as well-known as those of family I 
PPases (Heikinheimo et al. 1996, Baykov et al. 2000, Belogurov et al. 2000, 
Heikinheimo et al. 2001, Pohjanjoki et al. 2001, Halonen et al. 2002, Oksanen et al. 
2007). Briefly, the mechanism is the following: Metal-activated PPase binds a metal-
bound substrate (MgPPi or Mg2PPi, Cooperman et al. 1992), resulting in the 
breakdown of the P-O bond between the two phosphates of pyrophosphate. This occurs 
via nucleophilic attack of a transient hydroxide formed by abstraction of a proton from 
a water molecule activated by a two-metal cluster (Heikinheimo et al. 1996, 2001). The 







1.3.3.1 Metal binding 
 
PPases are phosphohydrolases dependent on the presence of divalent metal cations 
in the active site for catalytic activity. As shown in figure 4, two metal ions bind to the 
N-terminal DHH domain of family II PPases to form a two-metal center, while the 
third and fourth metal ions bind with substrate (Merckel et al. 2001, Parfenyev et al. 
2001, Fabrichniy et al. 2007). A water molecule is coordinated between the two metal 
ions (Ahn et al. 2001, Merckel et al. 2001). The metal cofactor of choice of family II 
enzymes is Mn2+ (Kuhn et al. 1998, Shintani et al. 1998, Young et al. 1998, Parfenyev 
et al. 2001, Halonen et al. 2005). Other divalent cations provide for lower catalytic 
efficiency (Zyryanov et al. 2004, Halonen et al. 2005). Family II PPases have ~20-fold 
higher activity with Mn2+ compared to the Mg2+ form of family I PPases (Parfenyev et 
al. 2001, Zyryanov et al. 2004b). However, the presence of Mg2+ is required for 
maximal activity (Parfenyev et al. 2001). 
 
The metal binding sites M1 and M2 have similar structures in the family II PPases 
of Streptococcus gordonii (sgPPase), Streptococcus mutans (smPPase) and Bacillus 
subtilis (bsPPase) (Merckel et al. 2001, Ahn et al. 2001, Fabrichniy et al. 2007). Sites 
M1 and M2 are highly integrated into the active site, and are formed by residues H9, 
D13, D75, H76 and D15, D75, H97, D149, respectively. When site M2 binds a metal, 
H97 moves away from contact with D75 and forms a trigonal bipyramidal site. 
Substrate hydrolysis apparently requires octahedral conformations of both sites, which 
can only form if site M2 is occupied by a metal (such as Mn2+ or Co2+), which supports 
the adoption of this configuration (Fabrichniy et al. 2004). Mg2+ and Zn2+ typically fail 
to induce this conformation (Harding 2001). 
 
The metal bound to site M2 is a determinant of quaternary structure and catalytic 
properties of family II PPases. In the absence of an activating metal in this site, family 
II PPases dissociate into monomers, and both monomer and dimer forms are inactive 
(Parfenyev et al. 2001). Co2+ and Mn2+ are able to support PPi hydrolysis (Zyryanov et 
al. 2004b), where site M2 binds Mn2+ or Co2+ with nM affinity and has µM affinity for 
Mg2+ (Parfenyev et al. 2001, Zyryanov et al. 2004b). Mn2+-activated family II sgPPase 
has a 15-fold higher kcat than Mg
2+-activated family I scPPase (Fabrichniy et al. 2004), 
while the kcat for Mg
2+-activated sgPPase is the same as for scPPase (Zyryanov et al. 






while PPi hydrolysis and Pi release are accelerated in comparison to scPPase 
(Fabrichniy et al. 2004). Mg2+-activated smPPase has higher affinity for PPi compared 
to Mn2+ (Zyryanov et al. 2002). However, Mn2+ and Mg2+ bind (Parfenyev et al. 2001) 
and activate sgPPase equally when bound to sites M1, M3 and M4 (Fabrichniy et al. 
2004). Site M1 may have increased affinity for transition metals when substrate or 
product is bound to the active site (Fabrichniy et al. 2007). Substitution in any of the 
metal binding sites decreases kcat and metal binding affinity by >10
5-6-fold (Halonen et 
al. 2005). 
 
The histidines in the family II PPase active site are good ligands especially for Zn2+, 
which binds with pM affinity to sgPPase and bsPPase, but fails to activate PPi 
hydrolysis (Kuhn et al. 1998, Parfenyev et al. 2001, Fabrichniy et al. 2004, Zyryanov 
et al. 2004a, 2004b). Zn2+ bound to site M1 supports PPi hydrolysis when Mn
2+ or 
Mg2+ are bound to site M2, but slowly displaces them (Zyryanov et al. 2004a). 
Otherwise, Zn2+ is a poor activator of family II PPase (Zyryanov et al. 2004a, 
Fabrichniy et al. 2004). Mg2+ also displaces the Mn2+ bound to site M2, if not present 
in the reaction (Parfenyev et al. 2001). PPi hydrolysis by Methanococcus jannaschii 








Figure 4. Stereoview of the superposition of the active sites of wild type and the H98Q variant 
of bsPPase in complex with the substrate analog imidodiphosphate (PNP) (adapted from 
Fabrichniy et al. 2007). The PNPs are shown as sticks, while metals, water and fluoride are 
shown as spheres. Hydrogen and coordination bonds to the Pis and metals are shown as broken 
lines. 
 
1.3.3.2 PPi binding and hydrolysis 
 
As shown in figure 4, substrate binds directly to a conserved section of the active 
site within the DHHA2 domain (Konopka et al. 2002, Ahn et al. 2001, Merckel et al. 
2001), which induces a conformational change to the “closed” form of sgPPase (Ahn et 
al. 2001). This results in the movement of the N- over the C-terminal domain, and 
aligns residues in the active site for catalysis (Merckel et al. 2001, Ahn et al. 2001). 
 
The Pi binding sites in the active site are designated P1 and P2. PPi is bound first to 
site P2, resulting in the closure of the structure (Shizawa et al. 2001, Ahn et al. 2001), 
and requires a change in the coordination number of site M2 from 5- to 6-coordinated 
(Fabrichniy et al. 2004). Site P1 is indeed fully formed in the bsPPase. Mn2 structure 
(Ahn et al. 2001). D203, R295 and K296 bind PPi in bsPPase, the latter two residues 
being part of the SRKKQ motif in the DHHA2 domain (Ahn et al. 2001, Merckel et al. 





al. 2007). R295 binds phosphate in site P2, while P1 interacts with the metals in sites 
M1 and M2. K205, the metal in site M3 and a water molecule interact with both sites 
P1 and P2, while D203 positions R295 for catalysis (Merckel et al. 2001, Fabrichniy et 
al. 2007). Thus, substitution of any of these residues increases Km (Halonen et al. 
2005). The DHHA2 domain restricts the active site for specific hydrolysis of PPi 
instead of other inorganic or organic polyphosphates, as partial deletion of this domain 
increases activity against P3 (Konopka et al. 2002). Family II PPases are thus unable to 
hydrolyze other substrates than PPi and are not inhibited by polyphosphate (Zyryanov 
et al. 2002), but are weakly inhibited by fluoride (Kuhn et al. 2000, Fabrichniy et al. 
2007). 
 
Scheme 1 shows the reaction scheme of family II PPase catalyzed hydrolysis of PPi 
(Zyryanov et al. 2004b). PPases transfer a phosphate from PPi to water in a single step 
without formation of a covalent enzyme-bound intermediate (Gonzalez et al. 1984). 
PPases also catalyze PPi synthesis (Baykov & Sheshtakov 1992) and Pi-H2O oxygen 
exchange (Springs et al. 1981). 
 
Scheme 1: PPi-Pi equilibration by family II PPase (Zyryanov et al. 2004b)
a 
 
a E = enzyme, M = Mn2+ or Mg2+, PP = PPi, P = Pi, n = 1 or 2. PPi binds as the Mg
2+-complex. 
The reaction involves PPi binding (k1-k2), hydrolysis (k3-k4), and stepwise release of two Pis (k5-
k6 and k7-k8). 
 
A single E-PPi intermediate has been observed in the catalytic cycle of family II 
PPase (Zyryanov et al. 2004b). Ahn et al. (2001) proposed that D98 is the general acid 
in the reaction, which protonates the leaving group phosphate in site P1. Even though 
substitution of this residue decreases kcat, it has no effect on the pKa of the general acid 
(Halonen et al. 2005). The DHH motif, however, has a critical role in catalysis, 
whereby D96 positions H97 and H98 for optimal interaction with PPi and other 
residues, such as the metal binding D76 (Ahn et al. 2001, Fabrichniy et al. 2007). The 
rate of conversion of EPPi into E(Pi)2 for Mn
2+-activated sgPPase is 17000 s-1 (k3), 
while the rate of the reverse reaction is 130 s-1 (k4). When Mn
2+ is replaced by Mg2+, k3 





1.3.3.3 Pi release 
 
The structures of product complexes show that the C-terminal domain is closed 
over the N-terminal metal-binding site (Ahn et al. 2001, Merckel et al. 2001, 
Fabrichniy et al. 2004). Pi release in family II PPases follows concurrent structural 
changes from a “closed” catalytic to a less active “open” conformation. The rate of 
product release is governed by factors which affect these structural changes causing the 
opening of the interface between the DHH and DHHA2 domains (Ahn et al. 2001). 
Family II PPases release metal-bound Pi in sequential steps. The structures with sulfate 
bound to both P1 and P2 in complex with Mn2+, Fe2+ (Fabrichniy et al. 2004) or Zn2+ 
(Merckel et al. 2001) show an opening and twisting of the C-terminus, where K205 
moves out of the active site, facilitating product release from site P2. However, site P1 
releases product first, as the first Pi released contains oxygen from the catalytic water 
molecule (Zyryanov et al. 2004b), and the bsPPase. Si structure is in the closed 
conformation (Fabrichniy et al. 2004), while the bsPPase. Mn2 structure has a fully 
formed P1 site (Ahn et al. 2001). The Pi from site P1 thus moves out of the active site 
through a channel formed by K205, Q80 and Q81 (Fabrichniy et al. 2004). The 
presence of Mn2+ promotes a 10-fold increase in the rate of Pi release in comparison to 
Mg2+ (Zyryanov et al. 2004b), while electrostatic repulsion between the Pis may also 









After the discovery and initial characterization of CBS-PPases, the research 
described in this thesis was undertaken with the primary goal being the expression, 
purification, and detailed kinetic characterization of this novel family of inorganic 
pyrophosphatases with an insertion composed of two CBS domains and a DRTGG in 
its N-terminal DHH domain. The primary hypothesis was that due to the presence of 
the adenosine nucleotide binding CBS domains, this subfamily would be regulated by 
adenosine nucleotides but otherwise be similar to other family II PPases lacking the N-
terminal insert. This hypothesis expanded to characterization of a unique family of 
enzymes able to hydrolyze both tripolyphosphate and pyrophosphate at essentially the 
same rates. Moreover, we wanted to uncover the mechanistic details of how CBS 
domains regulate CBS-pyrophosphatase function and properties in relation to the 
previously characterized family II PPases lacking the additional domains, and to 
elucidate the structural determinants of ligand binding and regulation, including the 
effects of human hereditary disease-associated single residue substitutions in CBS 
domains. The 3D structure of CBS domains is highly conserved, thus the goal was to 
be able to apply the information gained to other proteins containing CBS domains and 
to utilize the uncovered mechanistic details to elucidate the consequences of point 
mutations in CBS domains in the generation of human hereditary diseases. In short, 
this work has broad significance related to fundamental mechanisms of CBS domain 





3. EXPERIMENTAL PROCEDURES 
 
More detailed information on Materials and Methods used during this PhD work 
can be found in the section ORIGINAL PUBLICATIONS I-V. The following is a brief 
summary of these sections. 
3.1. Molecular biology, expression and purification 
 
The genes for the enzymes studied in this work were cloned into the pBluescript 
KS(-) or pUC19 cloning vectors using overlapping or inverse PCR (Stemmer & Morris 
1992), transformed into XL-1 Blue or TOP10 cells, extracted and subsequently either 
subjected to mutagenesis using the QuickChange method, a 4-primer mutagenesis 
method and/or directly transferred to a pET15, 22, 23, 32 or 36 expression plasmid. 
This plasmid was then transformed into either BL21(DE3)ril, C41 or C43 cells 
(Belogurov et al. 2002) and grown for 1–4 hours followed by 2–6 hours of induction of 
protein expression using 0.4–1 mM IPTG. Cells were disrupted either by sonication or 
by passage through a French press chamber. Protein purification was performed by 
conventional anion-exchange and gel filtration in either Tris or MOPS buffers mainly 
at pH 7.2 including MgCl2 and/or other metals, or by using Talon-Co
2+ IMAC or 
HisTrap for His-tagged proteins in the same buffers. CBS-PPase could be well 
separated from the endogenous E. coli PPase. To estimate molecular masses, proteins 
were fractionated by SDS-PAGE and protein was visualized by staining with 
Coomassie Brilliant Blue. Protein quantitation was performed by measuring the 
absorbance at 280 nm, by the Bradford assay, by direct vacuum dehydration and 
weighing, and by using the NanoOrange protein quantitation kit. 
3.2. Activity assays 
 
Measurements of the rate of phosphate production of PPases were performed with 
an in-line phosphate analyzer utilizing change in absorption caused by phosphate 
binding to molybdate in acidic medium (Baykov & Avaeva, 1981) or the BIOMOL 
green phosphate assay system (BioMol Corp.). The concentrations of each component 
were determined after consideration of the dissociation constants of the Mg2+, Na+, K+, 





using an N-[2-(1-maleimidyl)ethyl]-7-(diethylamino)coumarin-3-carboxamide 
(MDCC)-labeled E. coli periplasmic phosphate binding protein (Brune et al. 1994) 
with an SX18.MV stopped flow reaction analyzer (Applied Photophysics, UK) or a 
KinTek RQF-3 quenched flow apparatus with 32Pi. 
3.3. Binding assays 
 
Equilibrium binding reactions were performed with 14C-AMP and single-use 
DispoEquilibrium Dialyzers, a membrane filtration method utilizing 96-well filter-
bottom plates or fluorescence titration by monitoring protein Trp or Mant-nucleotide 
fluorescence. 
 
CBS domain nucleotide binding kinetics was characterized using fluorescently 
(Mant-) labeled nucleotides and an SX18.MV stopped flow reaction analyzer (Applied 
Photophysics, UK) with excitation at 295 nm or 355 nm and monitoring emission 
through a Schott GG filter (>400 nm). 
3.4. Phylogenetics 
 
Homology models were built using Modeller and the solved crystal structures of CBS 
domains from the PDB (mainly those of AMPK, IMPDH and CLC-5 in complex with 
different ligands, PDB-ID ZZZ, 1ZFJ, 2JA3). Multiple and pairwise structural alignments 
were performed using several online servers, but mainly the RAPIDO alignment software. 
Multiple alignments were generally built with the program Mafft v.6.3. 
 
Phylogenetic trees were made using the programs in the Phylip package (SeqBoot, 
ProtDist, Neighbor/Fitch/Kitsch, Consense), RAxML and PhyML, as well as, 
MrBayes. Trees were visualized mainly using Dendroscope, and iTol was used for 
publication purposes. 
 
3.5. Data analysis 
 
Initial rates were obtained from linear fits to the timecourses of phosphate 





rates, as well as, the rate of transition between them was obtained by fitting the 
timecourse to a differential equation describing the transition and associated 
parameters. The latter equations generally take into account a two-state transition 
between populations of inactive (or partially active) and active enzyme with depletion 
of substrate during the assay (Papers II, IV). Rates as a function of substrate or ligand 
concentration were then fit to the Michaelis-Menten or a similar hyperbolic equation, 
which provided kcat, Km, and Kd values (Papers I-IV). 
 
Transient kinetic timecourses were fit to a sum of exponentials, where the rates and 
amplitudes were further analyzed by fitting to simple hyperbolae (Papers II and IV). 
Fluorescence titration binding profiles were fit to differential equations describing the 
transitions from nucleotide-free enzyme to different nucleotide bound states taking into 
account the mass balance between different species in the reaction (Papers II, and VI-
V). 
 
The reported kinetic schemes are minimal, so that addition of a species to the 
models did not significantly improve the fit in terms of the sum of square of residuals, 
whereas elimination of a species did not make the fit significantly worse.




4. RESULTS AND DISCUSSION 
 
4.1 Discovery of CBS-PPases (Papers I, V) 
 
4.1.1 Novel subfamily of family II PPases 
 
A recent flood of sequenced genomes prompted a re-evaluation of the complement 
of enzymes hydrolysing linear inorganic polyphosphates. A number of novel 
multidomain fusion sequences with significant similarity to family II PPases were 
observed in the genomes of certain Archaea and Eubacteria (table 3). As described in 
figure 5, these sequences are composed of a DHH and DHHA2 domain, as well as, two 
CBS domains. Accordingly, the novel enzymes were named CBS-PPases, referring to 
the ~120-250 amino acid insertion in the N-terminal DHH domain. Most of these 
sequences additionally contain a DRTGG domain. This domain is named for the 
conserved amino acids found in its sequence, is also found in certain 
phosphotransacetylases, but has an as yet unknown function (Papers I, V). 
 
As shown in table 3, both types of family II PPases are found in the Eubacteria and 
Archaea, but not in eukaryotes. An exception is the intestinal protozoan parasite 
Giardia lamblia, which causes giardiasis. Interestingly, this early-diverging eukaryotic 
diplomonad, which reproduces by binary fission, has two nuclei with very similar gene 
content. Two encoded CBS-PPases are the only pyrophosphatases found in this 
organism and are very different from other CBS-PPases and thus provide an interesting 
future point of study regarding the evolution of CBS-PPases and of eukaryotes 
(Morrison et al. 2007). 
 
Family I PPases are much more widespread, occurring in all three kingdoms of life. 
Most family II PPases are found in the Firmicutes in completely sequenced genomes, 
with more than two thirds of these in the Bacilli and a fifth in the Clostridia. Of the 
total 421 family II PPases, a quarter (101/421) are CBS-PPases, distributed 
predominantly among the Firmicutes (54/101) and (16/101) proteobacteria. The 
majority of these contain both CBS domains and a DRTGG domain, while 
interestingly, the enzymes from Moorella thermoacetica, Synthrophomonas wolfeii, 




Syntrophothermus lipocalidus, Eggerthella lenta and Ethanoligenens harbinense 
(Paper V) lack the DRTGG domain but have retained the two CBS domains (Paper I). 
Table 3. Distribution of family II PPase in completely sequenced microbial genomes from the NR 
database (www.ncbi.nlm.nih.gov). The presence of CBS-PPase is indicated by a star (*). The 
number of species containing family II PPases is shown in parentheses. 
Archaea (24)  Eubacteria  Eukaryotes  
Crenarchaeota - Actinobacteria (7) + Alveolata - 
Euryarchaeota (24)* + Aquificae - Amoebozoa - 
Korarchaeota - Bacteroidetes/Chlorobi - Apusozoa - 
Nanoarchaeota - Chlamydiae/Verrucomicrobia (3)* + Centroheliozoa - 
  Chloroflexi - Cryptophyta - 
  Chrysiogenetes (1) + Diplomonadida* + 
  Cyanobacteria (1) + Euglenozoa - 
  Deferribacteres (3) + Fungi/Metazoa - 
  Deinococcus-Thermus (4) + Glaucocystophyceae - 
  Dictyoglomi - Haptophyceae - 
  Fibrobacteres/Acidobacteria (1) + Heterolobosea - 
  Firmicutes (251)* + Jakobida - 
  Fusobacteria (8)* + Katablepharidophyta - 
  Gemmatimonadetes - Malawimonadidae - 
  Nitrospirae (1) + Nucleariidae - 
  Planctomycetes (1)* + Oxymonadida - 
  Proteobacteria (109)* + Parabasalidea - 
  Spirochaetes (1) + Rhizaria - 
  Synergistetes (1) + Rhodophyta - 
  Tenericutes - Stramenopiles - 
  Thermodesulfobacteria - Viridiplantae - 
  Thermotogales (4)* +   
 
Figure 5 shows a sequence alignment of selected family II PPases. The polar active 
site residues present in family II PPases (Merckel et al. 2001, Ahn et al. 2001) are 
conserved in the CBS-PPases identified to date. The regulatory region possesses 27.9% 
identical residues overall with similar identities in individual domains. The insert is 
thus not well conserved in sequence among CBS-PPases. However, some highly 
conserved residues can be found (occurring in >90% of sequences): D72 in CBS1, 
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4.1.2 DRTGG domains enable P3 hydrolysis by CBS-PPase 
 
CBS-PPases were purified to homogeneity (≥98% purity) in the presence of 0.1 
mM Co2+ and 5-20 mM Mg2+ using a combination of anion-exchange and size-
exclusion chromatography. Initial characterization of the CBS-PPases from Moorella 
thermoacetica (mtCBS-PPase) (Paper I), Clostridium perfringens (cpCBS-PPase), and 
Fusobacterium nucleatum (fnCBS-PPase) (Paper V) at pH 7.2, 0.1 mM Co2+, 5 mM 
(mtCBS-PPase) or 20 mM Mg2+ (the rest) revealed that CBS-PPases are 100-1000-fold 
less active against PPi (Paper I, V) than the previously characterized family II PPases 
(Parfenyev et al. 2001). Maximal activity was displayed at pH 7.2 for both enzymes 
(Paper I, V). mtCBS-PPase had a kcat of 2.2  0.2 s-1 with a Km of 8  3 µM (Paper II), 
while cpCBS-PPase had a kcat of 50  3 s-1 and Km of 4.2  0.3 µM (Paper V). Assaying 
cpCBS-PPase against a range of inorganic and organic polyP substrates (PPi, P3, 
polyP25-1000, ATP, AP4, AP4A) for hydrolytic activity revealed that only PPi or P3 as 
substrate resulted in Pi production. In fact, the enzymes from Clostridium perfringens 
and Fusobacterium nucleatum (unpublished results) hydrolyze saturating 
concentrations of P3 at rates similar to PPi in contrast to any other known enzyme 
hydrolysing linear inorganic polyphosphates. cpCBS-PPase had a kcat for P3 of 55  15 
s-1 and a Km of 2.3  0.9 µM. In contrast, mtCBS-PPase, which lacks the DRTGG 
domain, possessed a weaker activity against P3 (<0.1 s
-1). Exhaustive hydrolysis of P3 
resulted in 1.5 times more Pi compared to PPi. This result confirmed that CBS-PPases 
are uniquely specialized short-chain inorganic polyPases (Paper V). Other family II 
PPases lacking the CBS-DRTGG insert possess an even weaker activity of 1/50,000 
against P3 in relation to PPi hydrolytic activity in optimal catalytic conditions 
(Parfenyev et al. 2001, Zyryanov et al. 2002). These results lead to the conclusion that 
the DRTGG domain somehow enables P3 hydrolysis by CBS-PPase. Perhaps this is 
due to structural or kinetic stabilization of protein-protein interactions or 











4.2 Ligand binding and regulation (Papers I-V) 
 
4.2.1 Co2+ is the best transition metal cofactor of CBS-PPase 
 
As metal ion-dependent phosphohydrolases require metal ions for catalysis, we 
evaluated the cation dependence of substrate hydrolysis by CBS-PPases. Cation 
dependencies were similar for both mt- and cpCBS-PPase, where maximal activities 
were observed in the presence of Co2+ and Mg2+. Metals other than Co2+ are less 
effective at activation of PPi and P3 hydrolysis, in the order 
Co2+>Mn2+>Ca2+>Zn2+>Mg2+. Also, metals other than Co2+ seem to leave rapidly the 
active site upon dilution or in the presence of an excess of other metals to yield a lower 
activity complex. The Co2+ complex is stable, however, even in the presence of 20 mM 
Mg2+ (Paper I, V). The family II PPase of Methanococcus jannaschii has similar 
cofactor specificity (Kuhn et al. 2000). In other known family II PPases, Mg2+ supports 
a moderate activity against PPi (Parfenyev et al. 2001, Zyryanov et al. 2004b). Thus 
Co2+ is the probable physiological ligand of CBS-PPases but Mg2+ is required for 
maximal activity. 
 
The PPi and P3 concentration dependencies of cpCBS-PPase were examined at fixed 
free Mg2+ concentrations. The dependencies obeyed the Michaelis-Menten equation. 
The dissociation constant for Mg2+ binding was 2–12 mM for free enzyme, and 1–4 
mM for the ES complex. Substrate was deduced to bind independently to the Co2+-
bound enzyme as either MgPPi or MgP3, and to bind one additional metal before 
hydrolysis occurs (Paper V). 
 
4.2.2 CBS-PPases are dimers 
 
Initially, it was observed that the CBS-PPases from cpCBS-PPase (Paper V) and 
fnCBS-PPase (Jämsen, unpublished results) were prone to aggregation, eluted at 
positions corresponding to tetramer and above during gel filtration and were soluble 
only at a concentration up to 5-15 mg/ml. However, mtCBS-PPase could be easily 
concentrated to above 100 mg/ml and displayed no higher order peaks in gel filtration, 
while migrating as a single band on native PAGE. Native PAGE analysis of cpCBS-
PPase produced a smear of bands around the MW of 60 kDa with some of the sample 




remaining in the well. Further, sedimentation and cross-linking experiments in the 
presence of Co2+ demonstrated that 10 µM mtCBS-PPase (Paper I), 9 µM cpCBS-
PPase and 36 µM cpCBS insert, the latter including 2xCBS domains and one DRTGG 
domain (Paper III), are dimers in solution. The sedimentation coefficient (s020,w) for 
mtCBS-PPase was 7.7 ± 0.1 S in the presence of Co2+ and 6.4  ± 0.1 S in the absence of 
metals (Paper I), while the same values for cpCBS-PPase were 8.4 ± 0.4 S and 4.9 ± 
0.1 S (Paper III), respectively. Metal identity (Mg2+, Mn2+ or Co2+) or addition of 
nucleotides (AMP for cpCBS-PPase and AMP, ADP, ATP for mtCBS-PPase) had a 
negligible effect on oligomeric status (Papers I, III). However, the sedimentation 
coefficient for the insert remained approximately the same, indicating that it remains 
dimeric, while the full-length enzyme dissociated into monomers in the absence of 
metals (Paper III). The results parallel those for other family II PPases, where 
transition metals stimulated dimerization, whereas dimers dissociated into monomers 
upon metal removal (Parfenyev et al. 2001). The fact that mtCBS-PPase, which lacks 
the DRTGG domain, has no propensity for aggregation at concentrations up to 1 mM, 
and cpCBS-PPase displays severe aggregation at <100 µM suggests that the DRTGG 
domain has a role in multimerization of CBS-PPase. This is supported by the DRTGG-
mediated oligomerization of phosphotransacetylase (Campos-Bermudez et al. 2010, 
Xu et al. 2005). 
 
4.2.3 Regulation by adenosine-containing effectors 
 
A wide range of ~80 adenosine- and other nucleoside-containing compounds were 
tested for effects on PPi hydrolytic activity with mt- (Paper I) and cpCBS-PPase, in 
addition to effects on P3 hydrolytic activity for the latter (Paper V). At saturating (200 
µM) substrate concentration, most adenine nucleotides (100 µM) affected the PPi 
hydrolytic activities of mtCBS-PPase, where other diphosphate containing nucleotides 
also had an effect. Diadenosine nucleotides had no effect on hydrolysis by mtCBS-
PPase (Paper I). For cpCBS-PPase, (di)adenosine nucleotides had an effect on PPi 
hydrolysis, except for cAMP, AP4 and AP2A, and activity against P3 was strongly 
affected by guanine nucleotides (GMP, GDP, GTP) (Paper V). Regulation by adenine 
nucleotides is unique to CBS-PPases among inorganic pyrophosphatases and suggests 
a link to regulation of PPase activity via changes in overall metabolic energy levels. 
 




The effects of AMP, ADP, and ATP on initial rate of mt- and cpCBS-PPase, 
including effect of AP4A on the latter, were studied as a function of nucleotide and 
substrate concentrations (Papers I, V). Figure 6A shows representative concentration 
dependencies for mtCBS-PPase at saturating Mg2PPi concentration (200 μM). ATP 
was found to activate mtCBS-PPase 1.6-fold with a Kd of 0.20 ± 0.05 µM, while AMP 
and ADP inhibited 27 and 590-fold, respectively with Kd values of 0.22 ± 0.02 and 
0.012 ± 0.001 µM (Paper I). For cpCBS-PPase, AMP and ADP inhibited 33-fold with 
Kd values of 1.4 ± 0.4 and 3.6 ± 1.3 µM, while ATP and AP4A activated 2.7 and 3.6-
fold, with Kd values of 24 ± 9 and 0.18 ± 0.05 µM, respectively. With P3 as substrate, 
AMP inhibited to zero with a Kd of 0.7 ± 0.1 µM, ADP inhibited 50-fold with a Kd of 
18 ± 4 µM, while ATP and AP4A activated 1.9 and 2.8-fold with Kd’s of 210 ± 20 and 





























Figure 6. A) Concentration dependence of mtCBS-PPase activity at fixed [PPi] (200 µM), B) 
Double-reciprocal plots of mtCBS-PPase activity as a function of substrate concentration at 
various fixed AMP (upper panel) and ADP (lower panel). The line marked ATP shows the 
effect of 10 µM ATP. The insets show secondary plots of derived parameters against 
[nucleotide] (Paper I). 




Determination of inhibition and activation type, as shown in representative figure 
6B, revealed that AMP inhibition was of competitive type for both mt- and cpCBS-
PPase, whereas ADP inhibition and ATP activation were of mixed types for mtCBS-
PPase, similarly to AP4A activation type with cpCBS-PPase (Paper I,V). 
 
The above results lead to the conclusion that CBS domains internally inhibit CBS-
PPases compared to family II PPase lacking this regulatory region making the catalytic 
domain sensitive to structural changes caused by adenine nucleotide binding to the 
CBS domains (Paper I). The binding affinity and type of effect of ligands on CBS-
PPases thus seems to be determined by the length of the phosphate chain and presence 
of the stabilizing DRTGG domain. Monophosphates, in fact, seem to work better as 
inhibitors of cpCBS-PPase (Paper I) compared to mtCBS-PPase, where ADP and other 
nucleotide diphosphates possess a more profound inhibitory potential than 
monophosphates (Paper V). Both types apparently stabilize inactive conformations of 
CBS-PPases. Three or more phosphate residues seem to be required for activation, 
where ATP activates both mt- and cpCBS-PPase, but with a much higher Kd than 
(di)adenosine polyphosphates with ≥3 phosphate residues. The activators seem to 
stabilize thermodynamically unfavorable conformations. ADP and ATP can bind to the 
enzyme-substrate complex and free enzyme, whilst AMP can only bind to the free 
enzyme (Paper I, V). The type of effect seems to be independent of the identity of 
metal activator, as determined for mtCBS-PPase in the presence of Mn2+, but the 
magnitude of the effect was lower (Paper I). Additionally, presence of the DRTGG 
domain enables regulation by diadenosine nucleotides in addition to monoadenosine 
nucleotides (Paper III, V) perhaps due to greater flexibility in the regulatory insert and 
stabilization of the interaction between CBS domains, as these are notoriously flexible. 
 
4.2.4 Substrate- and nucleotide-induced transitions 
 
Addition of PPi to a solution of mtCBS-PPase in the presence of 0.1 mM Co
2+, 5 
mM Mg2+ at pH 7.2, and detection of resulting Pi accumulation, revealed a pre-steady 
state activity transition during the timescale (~30 min) of the assay (Figure 7A). The 
transition occurred from a lower activity to a higher activity with a halftime of 1 
minute. 






Figure 7. A) Timecourse of PPi hydrolysis by mtCBS-PPase at pH 5, 7.2, and 9 in the presence 
of 100 µM Mg2PPi, 0.1 mM Co
2+, and 5 mM Mg2+ in comparison to the linear timecourse of E. 
coli PPase at pH 7.2 in the same conditions. B) dependence of k, A0 and Alim on increasing 
[AMP] determined in the same conditions as in A (Paper II). 
 
This type of phenomenon is commonly presented, among other possibilities, when 
the enzyme exists in at least two different conformations (or populations of) at the 
beginning of the reaction, which interconvert to bind substrate (EE*+SE*S) or as 




a consequence of substrate binding (E+SESE*S) (Paper II). In contrast, cpCBS-
PPase displayed a burst of product formation during the first ≤0.1 sec of PPi 
hydrolysis, as determined with stopped-flow analysis of phosphate production via 
MDCC-labeled E. coli Pi-binding protein (unpublished results). This phenomenon is 
presented, for example, when there is a conformational change following formation of 
a reaction intermediate accompanied by product release. 
 
Characterization of the transition observed for mtCBS-PPase in terms of a simple 
two-state model accounting for initial (A0) and final (Alim) activities, as well as, the rate 
of transition (k) between them, revealed that the substrate concentration dependence at 
various pH values could be accounted for by the Michaelis-Menten equation. Variation 
in pH generally slowed down the transition (basic pH) or inactivated the enzyme 
(acidic pH), while Km values were similar. Omission of Co
2+ or Mg2+ resulted in a 
linear Pi production curve. Importantly, incubation as a function of [E] or pH had no 
effect on the shape of the timecourse, indicating that the transition results from effects 
other than changes in oligomerization. The above data also indicates that the transition 
occurs in the ES complex and not in free E. Interestingly, increasing [AMP] led to an 
inactivating transition of the enzyme in contrast to activation in its absence, while the 
rate of transition approached zero at infinite AMP concentration (figure 7B). The 
dependencies revealed two nucleotide binding sites with apparent dissociation 
constants of ~0.5 and ~5 µM. The approximate fractions of each form of mtCBS-PPase 
could further be estimated from kinetic titration of ADP tight-binding sites (paper III). 
In the absence of substrate, the more active form comprised 15-33% of the stock 
enzyme, being more sensitive to effects of ADP (and AMP), while specific activities of 
the different forms differed 10-fold, yielding a 2.5-fold increase in activity (paper II). 
Similar differentially active enzyme forms have also been observed for the endosomal 
ClC-5 protein, a Cl-/H+ antiporter regulated by CBS domains (Zifarelli & Pusch 2009). 





Figure 8. A) Stopped flow fluorescence traces of 500 µM Mant-AMP binding to 5 µM mtCBS-
PPase at pH 7.2, 0.1 mM Co2+, 5 mM Mg2+ (left), in the presence of 500 µM PPi (middle) and 
binding of 30 µM Mant-AMP to a mixture of 250 µM AMP and 30 µM Mant-AMP. The upper 
panels show the distribution of residuals in the fit. Excitation of Trp fluorescence was at 295 
nm, while Mant emission was monitored at >400 nm. Fitting was to two- or three exponential 
equation. B) Dependence of the inverse transit times (left) and amplitudes (right) derived from 
A) on [Mant-AMP] (right). Fitting was to hyperbolic equations. 
Stopped-flow measurements using a fluorescent AMP analogue, 2'-(3-')-O-(N-
methylanthraniloyl)-AMP (Mant-AMP) were used to directly monitor nucleotide 
binding to CBS domains. These measurements utilized an increase in fluorescence 
resonance energy transfer (FRET) between W128 and Mant-AMP, located in the 
boundary between the regulatory and catalytic domains. In other words, protein 
fluorescence was excited at 295 nm and Mant-AMP fluorescence emission was 




monitored at 455 nm upon mixing enzyme with Mant-AMP. As shown in figure 8A, 
nucleotide binding revealed a 3-step increase in Mant-AMP fluorescence emission 
upon binding to mtCBS-PPase with relaxation times of 25 ms, 12 s, and 156 s implying 
large conformational changes in the complex (Paper II). When mixing Mant-AMP with 
cpCBS-PPase, there were only two transitions, with relaxation times of 10 and 4 ms 
(Paper V). In both cases, the binding step was too fast to be observed with our 
apparatus. In the case of mtCBS-PPase, the effect was reversed by addition of 
unlabeled AMP in two steps with relaxation times of 0.85 and 20 s (Paper II). The 
relaxation times and amplitudes of the fluorescence signals of mtCBS-PPase depended 
on [Mant-AMP] in a hyperbolic manner, which suggests the presence of two binding 
sites on the protein with Kd values of <1µM and 10 µM (figure 8B, Paper II). The 
dependence of the relaxation times of cpCBS-PPase displayed hyperbola with a Kd 
value of 20 µM (Paper V). Mixing mtCBS-PPase with Mant-AMP in the presence and 
absence of different metals indicated that addition of Mg2+ seemed to generally 
decrease the rates of all 3 steps of the nucleotide-induced transition, while metal-
depleted rates of steps 2-3 by 3-fold, and Co2+-bound enzyme increased rates of steps 
1-2 by 12-fold. Mg2+ and Co2+ increased the amplitude of step 3, while metal-depleted 
enzyme displayed lower amplitude for this step. Addition of PPi to a mixture of Mant-
AMP and enzyme at catalytic concentrations was shown to produce a distinct 
conformation separate from the conformations generated by nucleotide binding. This is 
also supported by AMP incubation with enzyme prior to substrate addition in Pi 
accumulation measurements (Paper II). 
 
Equilibrium fluorescence titration experiments with mtCBS-PPase and increasing 
concentrations of Mant-AMP or unlabeled AMP also supported the presence of two 
binding sites with dissociation constants of 1 and 10 µM, whereas equilibrium dialysis 
and membrane filtration measurements with 14C-AMP revealed binding of one AMP 
molecule per enzyme monomer with a Kd of 10 µM (Paper II). Interestingly, AMP 
caused a decrease, while AP3A– AP6A caused an increase and AP2A failed to induce a 
change in cpCBS-PPase intrinsic protein fluorescence, indicating that different 
conformations are generated by these compounds. Mant-AMP and AP4A had Kd values 
of 60 ± 20 and 0.4 ± 0.1 μM, respectively (Paper V). Collectively, these observations 
suggest negative cooperativity in nucleotide binding. The site with the lower Kd value 
is probably the inhibitory site, while the other site is a modulatory site. Nucleotides are 
unable to induce interconversion of the populations without addition of substrate and 




generate a conformation which could be distinguished in our studies. Overall, the data 
suggest a tight coupling between the regulatory and catalytic domains. 
 
4.2.5 The structural basis of regulation 
 
In paper III, we presented the structure of the regulatory region of cpCBS-PPase. 
The insert consists of two CBS domains separated in sequence by 118 residues 
corresponding to the DRTGG domain, in complex with two molecules of AMP in one 
structure per PPase dimer, and one molecule of AP4A in the other. The topology of the 
CBS domains is similar to that of several previously solved structures of CBS domains, 
while the structure of DRTGG domain was determined for the first time. Figure 9A 
shows a model of the full-length structure of cpCBS-PPase, which includes the 
determined structure of the regulatory insert. The two CBS domain pairs are adjacent 
to each other, while the DRTGG domains are next to them, proximal to the catalytic 
domains. 
 
Upon superimposition of the CBS domain dimers, the activator and inhibitor-bound 
structures display a difference in conformation. The adenine in both the AMP and 
AP4A structures interacts with M114 from CBS1, and Y278, N280 and V258 from 
CBS2. The ribose sugar hydrogen bonds to N119 and T253 in CBS2, while the 
phosphate of AMP interacts with S116, S118 and K100 from the other subunit. In the 
activated structure bound to AP4A, the ribose interacts with S116 and S118, while the 
phosphates are bound by S279 and K100 from the other subunit. Thus, activator 
binding shifts the RY278SN loop connecting α-helix1 and β-strand2 of CBS2 by 4.2 Å, 
leading to an opened CBS2 domain dimer interface. This in turn may allow the 
DHHA2 domain to move more freely relative to the DHH domain and so fine-tune the 
structure for catalysis. Figure 9B shows the two segments between the catalytic and 
regulatory domains (residues 66–70 and 305–308), which may be responsible for 
signal transduction between these domains. The regulatory region is also close to 
D311, which coordinates metals, and through which changes in conformation may 
affect catalysis. Dimerization is head-to-head in the CBS tetramer, with the dimer 
contacts formed by the two α-helices of CBS1 and helix 5 of the DRTGG domain. 
These contacts change little in inhibited vs. activated structures, indicating that 
oligomerization of cpCBS-PPase is not affected by nucleotide binding. 






Figure 9. A) Homology model of the structure of dimeric full-length cpCBS-PPase with active 
sites highlighted in black and CBS domain binding site in yellow. The DHH domain is in 
yellow, DHHA2 in red, DRTGG in orange, and CBS domains are in blue and cyan (Paper III). 
B) Elements of the interdomain signal transduction system, which transmits the signal from the 
regulatory to the catalytic domain. The arrows show possible movement in the depicted 
segments.  
4.2.6 Possible physiological functions of CBS-PPases 
 
Biosynthetic reactions produce PPi, the intracellular concentration of which 
increases during the logarithmic phase of microbial growth. The PPi must be degraded 
so as to prevent inhibition of critical biosynthetic reactions (Heinonen et al. 2001). 
High ATP concentrations enable microbial growth, but this also stimulates the CBS-




PPase mediated hydrolysis of the PPi produced by these ATP-dependent reactions, as 
CBS-PPases are activated by ATP and inhibited by AMP and ADP. In contrast, when 
growth slows down, the decrease in the [ATP]/([AMP]+[ADP]) ratio would inhibit 
PPase activity. During the latter phase, membrane PPase is able to maintain 
metabolism by creating an H+ potential gradient across various membranes together 
with H+-ATPase (Paper I). E. g., a basal level of PPi is maintained in E. coli even when 
[PPase] increases, thus the control of PPase activity is crucial to the maintenance of 
metabolism under cellular stress (Heinonen et al. 2001). 
 
The P3 hydrolytic function of CBS-PPases, which possess a DRTGG domain in 
addition to two CBS domains, seems to be the predominant activity of this enzyme, as 
the kcat/Km ratio of cpCBS-PPase for P3 at 1 mM Mg
2+ (approximate physiological 
concentration) is about 11 times higher than for PPi. There is an E. coli-type PPX in 
Clostridium perfringens, which degrades longer chain polyphosphate and is inhibited 
by P3, which CBS-PPase is able to degrade into phosphate, thus partly completing the 
phosphate metabolic cycle. cpCBS-PPase is the only PPase in Clostridium perfringens, 
and so the PPi hydrolytic activity is also significant (Paper V). 
 
4.3 CBS Domain mutational analysis (Paper IV) 
 
We generated enzyme with point mutations in the CBS domains of mtCBS-PPase 
and characterized their effects on catalytic efficiency, interactions with adenine 
nucleotides, and effects on the previously observed substrate-induced transition of 
mtCBS-PPase (Paper II). 





Figure 10. Model of the CBS domains (CBS1 above, CBS2 below) of mtCBS-PPase with 
bound AMP based on the structure of cpCBS (PDB ID 3LB2, Paper III). The residues chosen 
for substitution in this study are labeled. Residue numbering is for mtCBS-PPase. The primed 
AMP is located in the other subunit. 
As shown in figure 10, the residues corresponding to Lys100, Tyr169 and Arg170 
in the CBS domains of mtCBS-PPase bind the AMP. V99 is in the same position as 
Y169 in CBS2, while residues at positions 168−170 are part of a conserved RYRN 
loop. Based on the crystal structure, conformational changes in this loop between 
activated and inhibited enzyme are thought to control coupling between the CBS and 
PPase domains. We mutated most residues into alanine, conservatively replacing Y169 
with phenylalanine, while K100 and R187 were substituted with glycine, because these 








4.3.1 CBS and PPase domains are tightly coupled in native CBS-PPase 
 
The effects of mutations on the activity at the end of the reaction (Alim) was used to 
quantify the effects of CBS domain mutations on catalysis. The effects on kcat could be 
divided into three groups (table 4): (i) similar to wild type (K100G), (ii) more active 
(V99A, R168A, Y169A, Y169F, Y188A, H189A) by 1,3-3,3-fold, and (iii) less active 
(R170A, R187G) by 2,5-fold. The Km in each case was approximately 10 µM for all 
variants within experimental error. The fact that substitutions in a regulatory domain 
affect catalysis to such a large extent, signifies that the two domains are tightly coupled 
to each other and that even small changes in the structure of one domain are translated 
to changes in the other. Since the majority of substitutions caused an increase in 
catalytic efficiency (kcat/Km), overall the results support the hypothesis that the CBS 
insert functions as an autoinhibitor of CBS-PPase, where mutations either increase or 
decrease the inhibitory coupling between domains. 
 
4.3.2 Effects on nucleotide binding and inhibition 
 
As shown in table 4, AMP and ADP generally inhibited most variants similarly to 
wild type. A remarkable activation of 1.2- and 2.8-fold by AMP was observed with the 
substitutions Y169A and R168A, respectively. The degree of AMP inhibition was 
increased by the substitutions Y188A and H189A. The kinetically determined AMP-
binding affinity (Ki,app) was significantly lower in V99A, R168A and Y169A, while an 
increase of 10-100 fold was observed with the substitutions R187G and H189A. The 
stoichiometry of 14C-AMP binding was increased from 1 to 2 molecules per CBS pair 
in the variants Y169A, R170A, R187G and Y188A. This can be explained by 
conformational changes in CBS2, which increase affinity for nucleotides, decrease the 
negative cooperativity between domains, or change the interaction between CBS 
domain dimers. ADP inhibited all variants by around 5-fold, where the substitutions 
V99A, Y169A and R170A significantly decreased, while the substitutions Y169F, 
R187G and H189A increased the affinity of ADP to enzyme by 100-1000 fold. 
Elimination of the tyrosine ring of Y169 eliminated ADP binding and increased the Kd 
for AMP binding. 
 




K100 is thought to bind the first phosphate after the adenine ring, thus the 
substitution K100G decreased Ki and Kd for AMP while Ki for ADP was increased. 
Similarly, R170 binds the second phosphate of ADP, thus the substitution of this 
residue had the opposite effect on constants for AMP and ADP binding. In general, the 
substitution of residues K100, Y169 and R170, which were thought to change contacts 
with the nucleotide ligand based on the structure of cpCBS-PPase, had the expected 
effects on constants. The other substituted residues reside in a mobile loop (R168), 
which adopts different conformations in activated and inhibited form of the regulatory 
region, or are nearby in the structure (R187, Y188). R187 apparently has different 
conformations in activated and inhibited structures, while Y188 is a critical residue in 
the CBS dimer interface. The latter three residues were thus hypothesized to control the 
tight coupling between the CBS and PPase domains. 
 
Analysis of the effects of substitutions on the substrate-induced transition of 
mtCBS-PPase revealed that the ratio of initial to final activity (kcat,0/kcat,lim) was not 
much different from wild-type, except for the substitutions Y169A and R170A, which 
displayed no transition. This can be explained by the substitutions decoupling the 
catalytic and regulatory domains, supported by the fact that these residues are part of 
the conserved RYRN loop, which undergoes the largest change in conformation when 
comparing AMP and AP4A bound structure of the regulatory region of cpCBS-PPase. 
The rate constant characterizing the transition was 1.5-3-fold lower in mutants in 
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